drugset / Trial / NCT01180296
Oral Progesterone for Prevention of Preterm Birth
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate whether daily oral micronized progesterone is effective in preventing recurrent spontaneous preterm birth (RSPB) and whether micronized progesterone use increases maternal serum progesterone levels.
Timeline
- Start
- 2006-11
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 400 mg | Oral |
Indications
No indication recorded.